Interestingly, FHIT was also successfully used as a therapeutic gene in cancer cell lines, where it triggers apoptosis, and several preclinical models of FHIT-null cancer, including lung, esophagus, pancreas, breast and leukemia [15]–[20]. Here, FHIT is linked to leukemia.